cataliesw
Joined: | Sat, Aug 12th 2023, 02:34 | Roles: | N/A | Moderates: | N/A |
Latest Topics
Topic | Created | Posts | Views | Last Activity |
---|---|---|---|---|
Engineered Phage Lysins | Feb 22nd, 01:16 | 1 | 81 | 3 days, 23 hours ago |
Cell Culture and Organ-On-A-Chip Model Development Services | Feb 22nd, 01:02 | 1 | 68 | 3 days, 23 hours ago |
Zebrafish Antibody | Feb 22nd, 00:41 | 1 | 75 | 4 days ago |
Development of FGFR-based Bispecific ADCs | Jan 24th, 01:49 | 2 | 639 | 2 weeks, 6 days ago |
antibody-drug conjugates | Jan 20th, 01:13 | 1 | 488 | on 20/1/25 |
plasmids | Dec 9th 2024, 20:34 | 1 | 798 | on 9/12/24 |
Latest Posts
Topic | Author | Posted On |
---|---|---|
Engineered Phage Lysins | cataliesw | 3 days, 23 hours ago |
The modular structure of lysin is composed of at least two domains, including an N-terminal catalytic domain (CD) for enzymatic hydrolysis and a C-terminal cell wall binding domain (CBD) for substrate recognition. Learn more:Engineered Phage Lysins | ||
Cell Culture and Organ-On-A-Chip Model Development Services | cataliesw | 3 days, 23 hours ago |
MFMM1-Flow is an easy-to-use device for long-term 2D/3D cell culture and mechanical shear stress studies by means of microfluidics. Learn more: Cell Culture and Organ-On-A-Chip Model Development Services | ||
Zebrafish Antibody | cataliesw | 4 days ago |
Danio rerio (zebrafish) is a small fish that shines in biomedical research. Zebrafish lay hundreds of eggs that develop externally, allowing scientists to manipulate genes and monitor early phenotypes in complex organisms. Learn more: Zebrafish Antibody | ||
Development of FGFR-based Bispecific ADCs | cataliesw | on 24/1/25 |
An appealing and innovative treatment is the bispecific antibody-drug combination (ADC), which delivers targeted cytotoxic drugs with increased efficacy and less non-specific cytotoxic effects while directly targeting tumor-associated cell-surface antigens. Learn more: Development of FGFR-based Bispecific ADCs | ||
antibody-drug conjugates | cataliesw | on 20/1/25 |
Antibody-drug conjugates (ADCs) inherit such superiorities and more remarkably, expand the therapeutic window of the conjugated drugs (payloads), which are usually highly toxic and diverse in their biochemical nature. |